Chief Executive Officer
Dr. Haber serves as Biomica’s Chief Executive Officer. He is a seasoned life-science and biotechnology executive with over 15 years of experience in a range of strategic and operational leadership roles. Previously served as the CEO of Therapix Biosciences (Nasdaq, TASE: TRPX), leading the company to a successful IPO on Nasdaq and advancing the Company’s programs to clinical stage. Dr. Haber’s extensive career also includes over a decade of service as Chairman and board member for various privately held and publicly traded companies. He has also held senior executive positions in diverse life science companies and a private investment firm. He holds a PhD in Pharmaceutical Science and an MBA in Finance & Financial Engineering, both from The Hebrew University of Jerusalem, Israel.